Turning agencies' blues into children's cheer

Share this article:
Hard to Swallow celebrated their Pharmapalooza win
Hard to Swallow celebrated their Pharmapalooza win

AbelsonTaylor delivered a perfect pitch of a different kind last night when the agency's in-house ensemble, Hard to Swallow, scooped up first prize at the industry's annual battle of the bands contest.

Pharmapalooza 6, organized by The CDM Group, attracted hundreds of healthcare marketers to BB King Blues and Bar in New York's Times Square for a charitable evening of live music, comedy, food, drink and great company. 

And while AbelsonTaylor will no doubt enjoy taking a year's worth of musical bragging rights back to Chicago, the real winner was The Children's Hospital at Montefiore (CHAM), for whom the event raised more than $80,000. This brings the total raised by the six Pharmapalooza events to in excess of $575,000.

Second place in last night's contest was CDMi's Urge to Merge, while ghg's Pharma's Daughter finished third. Also competing for the trophy were CDM Princeton's The Jughandles and Publicis Kaplan Thaler's Hot Flash.

Judging the contest were four music industry legends: J.P. Evangelista, senior director of music programming, industry relations and sales strategy, VEVO;  Bryan Grone, label relations, Spotify; Jack McMorrow, SVP, Atlantic Records; and Jason Spiewak, president and founder, JLS Artist Management and Noble Steed Music.

You can see more of the action at the Pharmapalooza 6 Facebook page.

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...